
ITONIC HOLDINGS LTD
ITOCNASDAQTrading Snapshot
- Day Range
- $0.28 β $0.28
- 52-Week Range
- $0.22 β $1.18
- Volume
- $2.81B
- Avg Volume
- $3.53B
- Shares Outstanding
- 117.0M
- Next Earnings
- Sep 20, 2026
Fundamentals Snapshot
- Annual Revenue
- $523,029
- Last Q Revenue
- $119,151
- P/E Ratio
- β
- P/S Ratio
- 9.4x
- EPS (TTM)
- $-0.32
- Dividend Yield
- β
Why Investors Own ITOC
- βHigh-growth profile β revenue up +4.6% YoY with expanding US Equity exposure.
- βHealthy economics β 43% gross margin and 22% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
About ITONIC HOLDINGS LTD
A company profile for ITONIC HOLDINGS LTD isnβt available yet β check back soon.
Otter Score Breakdown
βAnalyst Price Target
βLatest News & Updates

12 Health Care Stocks Moving In Friday's After-Market Session
Gainers China SXT Pharmaceuticals (NASDAQ:SXTC) shares moved upwards by 41.1% to $0.09 during Friday's after-market session. The market value of their outstanding shares is at $12.7 million. iTonic Holdings

12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Zhengye Biotechnology (NASDAQ:ZYBT) shares moved upwards by 24.0% to $1.71 during Wednesday's after-market session. The market value of their outstanding shares is at $135.0 million. Medpace Holdings

Top movers in Friday's after hours session
The US market regular session of Friday is over, let's have a look at the top gainers and losers in the after hours session today.

12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers GlucoTrack (NASDAQ:GCTK) stock moved upwards by 28.6% to $0.64 during Thursday's after-market session. The company's market cap stands at $3.3 million. Stereotaxis (AMEX:STXS) stock increased by 8.51%
Holdings Announces Continued Progress In Development Of Next-Gen AI-Enabled Treatment Planning System Cloud Platform Through Mili Medical
New cloud-based platform is being developed to integrate artificial intelligence, automated quality control and healthcare data connectivity to support next-generation precision medicine workflows.Beijing, China, July